Rendering

Component: (Network and Table)
Network
2309301 - Disclosure - Current and Long- Term Liabilities (Tables)
(http://www.amagpharma.com/role/CurrentAndLongTermLiabilitiesTables)
Table(Implied)
Slicers (applies to each fact value in each table cell)
Reporting Entity [Axis]0000792977 (http://www.sec.gov/CIK)
Payables and Accruals [Abstract]Period [Axis]
2016-01-01 - 2016-12-31
Payables and Accruals [Abstract]
 
Schedule of accrued expenses
Accrued expenses consisted of the following as of December 31, 2016 and 2015 (in thousands):
 
December 31,
 
2016
 
2015
Commercial rebates, fees and returns
$
89,466

 
$
45,161

Professional, license, and other fees and expenses
34,962

 
27,070

Interest expense
16,683

 
18,411

Salaries, bonuses, and other compensation
14,823

 
12,838

Restructuring expense
74

 
2,883

Total accrued expenses
$
156,008

 
$
106,363